Q&A With Jake Mann From the University of Cambridge: Looking at Comorbidities of Non-alcoholic Fatty Liver Disease

Video

Hepatologists are seeing a growing number of patients with non-alcoholic fatty liver disease in their practices. Finding the most effective ways to treat them has become a focus of the field. A recent study also looked at the link between this and similar conditions and cardiovascular disease.

Hepatologists are seeing a growing number of patients with non-alcoholic fatty liver disease in their practices. Finding the most effective ways to treat them has become a focus of the field. A recent study also looked at the link between this and similar conditions and cardiovascular disease.

Jake Mann, from the University of Cambridge discussed the results of one such study during the 2015 International Liver Congress in Vienna.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
© 2024 MJH Life Sciences

All rights reserved.